PRE
Prenetics Global LimitedNASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.81
P/S
2.91
EV/EBITDA
-6.01
DCF Value
$-1,092.81
FCF Yield
-8.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.0%
Operating Margin
-41.3%
Net Margin
-61.3%
ROE
-36.0%
ROA
-36.7%
ROIC
-22.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $36.6M | $-28.1M | $-1.75 |
| FY 2025 | $92.4M | $-58.3M | $-4.15 |
| Q3 2025 | $23.6M | $-7.4M | $-0.53 |
| Q2 2025 | $17.7M | $-12.4M | $-0.94 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
HK
Exchange
NASDAQ
Beta
0.27
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.